Publication | Closed Access
Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition
42
Citations
42
References
2010
Year
The effects of subconjunctival injection of bevacizumab in treating corneal NV associated with lipid deposition were significant in some patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1